Local MP Sir Jeffery Donaldson recently visited Cirdan’s Headquarters in Lisburn to discuss the company’s latest innovations and successes in global export markets.

During his visit, Sir Jeffrey met with Cirdan’s CEO, Dr Hugh Cormican, and had a full tour of our facilities, meeting with our development teams and seeing first-hand some of our latest innovations in pathology imaging, laboratory information systems and work in AI and Digital Pathology. He also discussed our participation in the Smart Nano consortium and how links between business and local education bodies are helping drive innovation.

Sir Jeffrey had a full demonstration of Solas OR, Cirdan’s newly launched X-ray specimen system designed for breast surgery and biopsy suites. Solas OR has been designed, developed, and built by our Lisburn based engineering team and incorporates the latest imaging technology to provide rapid image capture of quality specimen images with high contrast levels, excellent definition, and clear views of microcalcifications and lesions.

Solas OR is the newest member of Cirdan’s family of imaging products, including the macro imaging system PathLite and the breast biopsy system CoreLite, which are exported globally to over 20 markets.

Sir Jeffery is passionate about innovation and how Northern Ireland businesses can develop world-leading technologies to drive exports, build high-value local jobs, and create long-term economic development. He was is also interested in looking at how companies like Cirdan can win business closer to home, for example within the UK and our public sector tender awards.

“I was very impressed with the level of innovation, the development of globally competitive technologies and products, and the commitment of the Cirdan management team to the local supply chain. This investment, combined with continued growth in high-quality employment, can only be good for Lisburn and the overall Northern Ireland economy. Cirdan is a great example of an innovative, value-led business competing at a high level in global markets. I wish them success for their continued development and global expansion.”

Dr Hugh Cormican thanked Sir Jeffrey for his interest in Cirdan and his personal visit, “Like Sir Jeffrey, we are passionate about improving wellbeing through innovation, and we really appreciate the interest Sir Jeffrey has shown in our business. It was great to show him some of the innovative developments we are working on and how our products are changing patient experiences around the world.”